{"disease":{"id":"tace","name":"tace"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07417800","title":"Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07147335","title":"The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"The First Affiliated Hospital of University of South China","has_results":false},{"nct_id":"NCT07277192","title":"HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and Survival","phase":"","overall_status":"COMPLETED","enrollment_count":562,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT06483594","title":"Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (CHANCE 2407)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Shengjing Hospital","has_results":false},{"nct_id":"NCT07344116","title":"Hepatobiliary and Pancreatic Tumor Biobank","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07186621","title":"Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":286,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT07351669","title":"A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Zhongda Hospital","has_results":false},{"nct_id":"NCT07322848","title":"DEB-TACE vs cTACE in HCC After TIPS","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":206,"lead_sponsor_name":"First Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05889949","title":"Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07282184","title":"Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":144,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT07168668","title":"Partial Immune-boost TACE in unrEseCTable HCC Patients Under Systemic Treatment","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT05451615","title":"Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Zhejiang Provincial People's Hospital","has_results":false},{"nct_id":"NCT05970666","title":"Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":71,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT06091995","title":"Use of Belatacept to Delay Tacrolimus Initiation in Kidney Transplant Patients With Delayed Graft Function","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Methodist Health System","has_results":false},{"nct_id":"NCT05042336","title":"The Effectiveness and Safety of Camrelizumab/Lenvatinib Combined With TACE in Patients With Borderline Resectable HCC","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":49,"lead_sponsor_name":"Sichuan University","has_results":false},{"nct_id":"NCT07128251","title":"A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":47,"lead_sponsor_name":"Anhui Provincial Hospital","has_results":false},{"nct_id":"NCT05920863","title":"Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma with High-risk Recurrence Factors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT05131698","title":"Clinical Study of the Efficacy and Safety of Transhepatic Arterial Chemoembolization Combined With Tislelizumab and Lenvatinib in Patients With Advanced Unresectable Hepatocellular Carcinoma","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":31,"lead_sponsor_name":"Cancer Hospital of Guangxi Medical University","has_results":false},{"nct_id":"NCT04686929","title":"Abatacept s.c. for aGVHD Prevention in Haplo-HCT","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":29,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT07398664","title":"H101 Plus TACE for r/m HNSCC","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT04946669","title":"An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT07230080","title":"Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":17,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}